Participated · Equity · Jul 2026

Founded in January 2022 by Bruno Ruyú and fellow Instituto Balseiro alumni, Teramot offers an autonomous data engineering platform that automatically connects and normalizes disparate corporate data sources so AI agents can consume them. The company reports reductions of up to 90% in implementation time and cost savings around 10% compared with traditional data integration services. Teramot serves enterprise customers across Argentina, Brazil, Colombia and Paraguay, including Coca-Cola, Johnson & Johnson, La Caja and Grupo Sancor Seguros. The startup projects US$2 million in revenue for 2026 and is using its recent funding to consolidate regional presence and pursue expansion into the United States and the Middle East, with plans to open a Silicon Valley office. Its founding team's strong technical background from the Instituto Balseiro is highlighted as a core competitive strength.

Participated · Seed · Jun 2026

Founded in December 2024 by Germán Serrano and Hernán Asorey, Ab Astra develops advanced muongraphy technology that uses cosmic-ray muons to create high-definition images of the interior of large geologic bodies and critical infrastructure. The company targets exploration and production applications in mining of critical minerals such as lithium, copper, uranium and rare earths, and also cites dual-use applications in defense and nuclear sectors. Its technology combines compact next-generation sensors, reconstruction algorithms and AI-driven 3D/4D interpretation models that the founders say can deliver large improvements in spatial resolution versus comparable methods. Ab Astra plans to commercialize through a mix of measurement-and-analysis services, field equipment installation, and a continuous-monitoring platform for 4D subsurface interpretation. Current development work includes first-in-class sensor design, patio testing of initial units, algorithm development and preparation for pilot tests in salt flats (salares). The company positions its solution as a way to reduce exploratory costs, improve resource modeling and support environmental monitoring such as aquifer protection.

Participated · Seed · Oct 2024

Ergo Bioscience is a plant cell biotechnology company that grows engineered carrot cell lines in bioreactors to express complex animal proteins, an approach it positions as an alternative to microbial precision fermentation for proteins that yeast and bacteria produce poorly. Its EUKARYA platform combines gene editing, multi-omics and AI-guided cell line design, and its initial portfolio covers bovine myoglobin — the heme protein behind beef's colour, flavour and aroma — alongside alpha-S1 and kappa caseins for animal-free dairy, with immunoglobulins and a broader line of plant metabolites for food, personal care and health in development. The company is pre-revenue and awaiting regulatory clearance in the United States, its principal target market, and in 2022 partnered with Italy's Aethera Biotech to scale its bioprocesses on a plant cell culturing platform with capacity above 120 tonnes per year. Following an October 2024 investment from the Global Agri-Food Advancement Partnership, Ergo is opening offices and cell line R&D capabilities in Saskatoon, Saskatchewan, housed in GAAP's incubator labs, as its route into North America. Founded in 2019 by Alejandro Barbarini, Eduardo Peña and María Laura García, the company is headquartered in Sunchales, Santa Fe, with research split between the CITES incubator there and the National University of La Plata, a holding company in Delaware, and a team of around twelve as of 2023. Financially, Ergo raised a seed financing from CITES alongside public co-financing through Argentina's FONDCE, followed by investments from Pascual Innoventures in September 2023 and GAAP in October 2024; the articles do not disclose the amounts of the latter two rounds or a total raised to date.